Article Versions Notes

Ancel J, Birembaut P, Dewolf M, Durlach A, Nawrocki-Raby B, Dalstein V, Delepine G, Blacher S, Deslée G, Gilles C, et al. Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC. Cancers. 2019; 11(10):1411. https://doi.org/10.3390/cancers11101411

Ancel, Julien, Philippe Birembaut, Maxime Dewolf, Anne Durlach, Béatrice Nawrocki-Raby, Véronique Dalstein, Gonzague Delepine, Silvia Blacher, Gaëtan Deslée, Christine Gilles, and et al. 2019. "Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC" Cancers 11, no. 10: 1411. https://doi.org/10.3390/cancers11101411

Ancel, J., Birembaut, P., Dewolf, M., Durlach, A., Nawrocki-Raby, B., Dalstein, V., Delepine, G., Blacher, S., Deslée, G., Gilles, C., & Polette, M. (2019). Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC. Cancers, 11(10), 1411. https://doi.org/10.3390/cancers11101411